Goal 3: Advance Translational Research
To facilitate innovation and accelerate research translation, knowledge dissemination, and implementation science that enhances public health.
Showing 2 ideas for tag "hematopoietic"
Graft versus host disease (GVHD) remains the most significant complication of allogeneic hematopoietic stem cell transplantation (HCT). While the use of HCT has grown significantly safer and has demonstrated broad efficacy in the setting of a broad range of blood diseases, immunosuppressive therapy has not dramatically evolved since the introduction of calcineurin inhibitor-based approaches decades ago. The availability... more »
129 up votes
23 down votes
What are the best inroads for the NHLBI to support innovative approaches in the next 5-10 years, especially blood cell therapies based on hematopoietic stem cell and novel gene therapy approaches to control or even cure HIV infection?
15 up votes
31 down votes